#Knoxville #United States #Colorectal Cancer #ColoHealth #New Day Diagnostics

ColoHealth Blood Test: A New Era in Colorectal Cancer Screening

Colorectal cancer is a significant health concern, being the second leading cause of cancer-related fatalities in the United States. Notably, many adults avoid necessary screenings due to discomfort and invasiveness associated with traditional methods such as colonoscopies. Understanding these barriers, New Day Diagnostics has launched a revolutionary solution: the ColoHealth blood test. This innovation is designed to increase accessibility for those aged 50 and above who find themselves at average risk for colorectal cancer.

What is the ColoHealth Blood Test?

The ColoHealth blood test is a groundbreaking alternative to conventional screening methods, providing a non-invasive option for those hesitant to undergo procedures like colonoscopies or stool tests. What sets this test apart is its availability; patients can now access it directly, without needing a doctor's order in most states across the U.S. - excluding California and New York. The simple test allows individuals to take charge of their health, without having to set aside time for extensive procedures.

Exceptional Accuracy and Ease of Use

According to Eric Mayer, CEO of New Day Diagnostics, the ColoHealth test exhibits an impressive sensitivity rate of 73.3%, specificity rate of 81.5%, and a negative predictive value of 99.8%. These numbers not only underscore the test's accuracy but also the reassurance it can provide. Notably, it detects nearly double the pre-cancerous conditions compared to its competitors in the screening blood test category.

What further emphasizes the ColoHealth test’s efficacy is its impact on patient behavior: over 99% of those who hesitated to undergo earlier screening methods proceeded to complete the test, increasing the chances of early cancer detection significantly.

A Streamlined Three-Step Process

The ColoHealth blood test is designed to be user-friendly:

1. Answer Health Questions: Individuals begin by completing a brief online questionnaire to establish eligibility for the test.
2. Order Online: If approved, consumers can securely purchase their ColoHealth test through the dedicated website, ColoHealthy.com.
3. Schedule a Blood Draw: After order confirmation, patients can choose a convenient local lab from New Day's phlebotomy network and set an appointment for the blood draw.

Post-testing, if cancer markers are identified, the next step would be a follow-up colonoscopy for diagnostic confirmation.

Addressing the Screening Gap

Despite the significant risks connected to colorectal cancer, screening rates remain alarmingly low, driven by the discomfort associated with traditional methods. Consequently, the ColoHealth blood test aims to fill this gap by offering an accessible, less daunting screening alternative. Its ease-of-use maintains the potential to drive greater participation in routine health screenings, making strides toward earlier detection and better outcomes.

The potential impact of increasing screening participation cannot be overstated—early detection can lead to timely intervention, ultimately saving lives. With this test, New Day Diagnostics is not only offering a revolutionary product but propelling a crucial shift in how colorectal cancer screenings are perceived and executed across the nation.

To find out more details or place an order, interested individuals can visit www.ColoHealthy.com.

About New Day Diagnostics

Founded in Knoxville, Tennessee, New Day Diagnostics is a health innovation company dedicated to making diagnostic testing more accessible and patient-friendly. The company strives to enhance patient care by streamlining the path from discovery to diagnosis, especially during critical health moments.

In summary, the ColoHealth blood test represents a substantial leap forward in combating colorectal cancer, presenting a viable option that aligns with modern-day healthcare needs and preferences.